Home
>
National Drug Code (NDC)
>
Tacrolimus
Tacrolimus - 50742-207-01 - (tacrolimus)
Drug Information of Tacrolimus
| Product NDC: | 50742-207 |
| Proprietary Name: | Tacrolimus |
| Non Proprietary Name: | tacrolimus |
| Active Ingredient(s): | .5 mg/1 & nbsp; tacrolimus |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Tacrolimus
| Product NDC: | 50742-207 |
| Labeler Name: | Ingenus Pharmaceuticals, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA091195 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120928 |
Package Information of Tacrolimus
| Package NDC: | 50742-207-01 |
| Package Description: | 100 CAPSULE in 1 BOTTLE (50742-207-01) |
NDC Information of Tacrolimus
| NDC Code | 50742-207-01 |
| Proprietary Name | Tacrolimus |
| Package Description | 100 CAPSULE in 1 BOTTLE (50742-207-01) |
| Product NDC | 50742-207 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | tacrolimus |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20120928 |
| Marketing Category Name | ANDA |
| Labeler Name | Ingenus Pharmaceuticals, LLC |
| Substance Name | TACROLIMUS |
| Strength Number | .5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Calcineurin Inhibitor Immunosuppressant [EPC],Calcineurin Inhibitors [MoA] |
